Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Gastroenterol Hepatol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    April 2019
  1. WEINTRAUB Y, Cohen S, Chapnik N, Ben-Tov A, et al
    Clock Gene Disruption is an Initial Manifestation of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30373.
    PubMed     Text format     Abstract available


  2. ANANTHAKRISHNAN AN
    Reply to letter to the editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Apr 6. pii: S1542-3565(19)30365.
    PubMed     Text format    


    March 2019
  3. DAI C, Jiang M, Huang YH
    Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Mar 27. pii: S1542-3565(19)30298.
    PubMed     Text format    


  4. EGBERG MD, Galanko JA, Kappelman MD
    Patients Who Undergo Colectomy for Pediatric Ulcerative Colitis at Low-volume Hospitals Have More Complications.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30251.
    PubMed     Text format     Abstract available


  5. KHAN N, Lee H, Trivedi C, Kavani H, et al
    Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30254.
    PubMed     Text format     Abstract available


  6. ZANOLI L
    Increased Cardiovascular Risk in Patients With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:799-800.
    PubMed     Text format    


    February 2019
  7. BURISCH J, Jess T
    Does eradication of Helicobacter pylori cause inflammatory bowel disease?
    Clin Gastroenterol Hepatol. 2019 Feb 12. pii: S1542-3565(19)30153.
    PubMed     Text format    


  8. GRACIE DJ, Ford AC
    Functional Gastrointestinal Symptoms in Inflammatory Bowel Disease: Rising to the Challenge.
    Clin Gastroenterol Hepatol. 2019;17:572-573.
    PubMed     Text format    


  9. MINER PB JR
    Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Feb 1. pii: S1542-3565(19)30137.
    PubMed     Text format    


    January 2019
  10. FALECK DM, Winters A, Chablaney S, Shashi P, et al
    Shorter Disease Duration is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease but Not Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Jan 5. pii: S1542-3565(19)30013.
    PubMed     Text format     Abstract available


    December 2018
  11. RESTELLINI S, Chao CY, Martel M, Barkun A, et al
    Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis-a Systematic Review.
    Clin Gastroenterol Hepatol. 2018 Dec 21. pii: S1542-3565(18)31397.
    PubMed     Text format     Abstract available


  12. MA C, Kotze PG, Almutairdi A, Jairath V, et al
    Concomitant Use of Aminosalicylates Is Not Associated with Improved Outcomes in Patients with Ulcerative Colitis Escalated to Vedolizumab.
    Clin Gastroenterol Hepatol. 2018 Dec 7. pii: S1542-3565(18)31341.
    PubMed     Text format    


  13. WEAVER KN, Long MD
    Preventive Medicine in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31331.
    PubMed     Text format     Abstract available


    November 2018
  14. SANDBORN WJ, Panes J, D'Haens GR, Sands BE, et al
    Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
    Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31278.
    PubMed     Text format     Abstract available


  15. BERINSTEIN JA, Steiner CA, Regal RE, Allen JI, et al
    Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Nov 17. pii: S1542-3565(18)31265.
    PubMed     Text format    


  16. TARGOWNIK LE, Benchimol EI, Bernstein CN, Singh H, et al
    Upfront Combination Therapy, Compared with Monotherapy, for Patients Not Previously Treated with a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31246.
    PubMed     Text format     Abstract available


    October 2018
  17. AXELRAD JE, Olen O, Askling J, Lebwohl B, et al
    Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.
    Clin Gastroenterol Hepatol. 2018 Oct 30. pii: S1542-3565(18)31025.
    PubMed     Text format     Abstract available


  18. VANDE CASTEELE N, Jeyarajah J, Jairath V, Feagan BG, et al
    Infliximab Exposure-Response Relationship and Thresholds Associated with Endoscopic Healing in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Oct 26. pii: S1542-3565(18)31200.
    PubMed     Text format     Abstract available


  19. DAI C, Jiang M, Sun MJ
    The Association Between Consumption of Sweetened Beverages and the Risk of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018;16:1681-1682.
    PubMed     Text format    


  20. GOLDSMITH JR, Sartor RB
    Opioid Toxicity in Inflammatory Bowel Disease Patients Likely Includes Direct Enterocyte Effects That Exacerbate Disease.
    Clin Gastroenterol Hepatol. 2018;16:1679-1680.
    PubMed     Text format    


    September 2018
  21. HART AL, Bouri S
    Onset of action of Inflammatory Bowel Disease medications: how quickly do they really work?
    Clin Gastroenterol Hepatol. 2018 Sep 19. pii: S1542-3565(18)31012.
    PubMed     Text format    


  22. MORILLA I, Uzzan M, Laharie D, Cazals-Hatem D, et al
    Colonic microRNA Profiles, Identified by a Deep-learning Algorithm, That Predict Responses of Patients With Acute Severe Ulcerative Colitis to Therapy.
    Clin Gastroenterol Hepatol. 2018 Sep 14. pii: S1542-3565(18)30947.
    PubMed     Text format     Abstract available


  23. PELLET G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, et al
    Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination with Vedolizumab in Patients With Refractory Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Sep 10. pii: S1542-3565(18)30966.
    PubMed     Text format     Abstract available


  24. RAFFALS LE, Nguyen GC, Rubin DT, Nguyen GC, et al
    Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30943.
    PubMed     Text format    


  25. SOMINENI HK, Kugathasan S
    The microbiome in inflammatory bowel disease: from prevailing clinical evidence to future possibilities.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30957.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: